Check out our most popular compounded medications! Get Started
Valproate Sodium 250 mg Slow Release Capsules are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used in the treatment of conditions such as Epilepsy, Bipolar Disorder, Migraine, Schizophrenia, and Autism.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Valproate Sodium 250 mg Slow Release Capsules is a medication primarily used to manage a variety of neurological and psychiatric disorders. This includes conditions such as epilepsy, bipolar disorder, and migraine headaches. The formulation of these capsules is specifically designed to provide a slow and steady release of the active ingredient, valproate sodium, over an extended period of time. This allows for more consistent therapeutic effects and helps to reduce the risk of side effects associated with higher doses of valproate sodium.
The slow release capsules are formulated with Methocel E4M, a type of controlled-release polymer. This polymer is designed to release the encapsulated medication gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
In the case of bipolar disorder, it aids in reducing the frequency and severity of manic episodes. Additionally, it is used to treat migraine headaches, helping to reduce the frequency and severity of migraine attacks.
While Valproate Sodium 250 mg Slow Release Capsules are generally well tolerated, some common side effects include nausea, vomiting, and dizziness. Other potential side effects may include weight gain, hair loss, and changes in liver function. It is important for patients to be closely monitored for any signs of adverse effects while on this medication.
If you have any questions about Valproate Sodium 250 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of experienced compounding pharmacists is here to assist you in making the best decisions for your health.
Valproate Sodium 250 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This formulation is particularly beneficial for medications requiring a controlled and prolonged release profile.
It's important to note that Valproate Sodium 250 mg Slow Release Capsules may interact with other medications, supplements, or herbal products. Therefore, patients are advised to inform their healthcare provider of all medications, supplements, or herbal products they are currently taking. Known interactions include anticoagulants, aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and other medications used to treat seizures, depression, anxiety, or bipolar disorder.
Valproate Sodium may also interact with alcohol, barbiturates, carbamazepine, lamotrigine, phenobarbital, phenytoin, rifampin, and St. John’s wort. There are potential risks associated with these interactions, including an increased risk of liver damage, bleeding, suicidal thoughts or behavior, and birth defects. Therefore, it's crucial to discuss these risks with a healthcare provider before starting treatment.
Furthermore, Valproate Sodium may interact with certain foods. Patients should consult their healthcare provider before taking Valproate Sodium with any food or beverage. If you have any questions or concerns about this medication, please do not hesitate to reach out to your healthcare provider for further information and guidance.
Valproate Sodium 250 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as epilepsy, bipolar disorder, and migraine headaches. The unique slow-release formulation, which incorporates Methocel E4M, a controlled-release polymer, ensures a gradual release of the active ingredient over an extended period. This mechanism helps maintain a steady level of the medication in the body, providing consistent symptom control and sustained therapeutic effects.
The slow-release profile of Valproate Sodium 250 mg Capsules not only enhances the efficacy of the medication but also reduces the dosing frequency, thereby improving patient compliance. Valproate Sodium functions by reducing the levels of certain chemicals in the brain that can trigger seizures, mood swings, and headaches.
When using Valproate Sodium 250 mg Slow Release Capsules, it is crucial to adhere to the prescribed dosage and frequency. Overdosing or underdosing, as well as altering the dosing schedule, can affect the effectiveness of the medication and potentially lead to adverse effects. To minimize the risk of stomach upset, it is recommended to take the medication with food.
Some users of Valproate Sodium 250 mg Slow Release Capsules may experience side effects such as nausea, vomiting, dizziness, drowsiness, and headaches. If you encounter any of these symptoms, it is important to contact your healthcare provider immediately. Additionally, if you are pregnant or breastfeeding, it is essential to inform your doctor as Valproate Sodium may not be safe for use in these situations.
Understanding your medication is key to managing your condition effectively. If you have any queries about Valproate Sodium 250 mg Slow Release Capsules, do not hesitate to seek professional advice. Always remember, your health and well-being are of utmost importance.
Valproate Sodium 250 mg Slow Release Capsules are a specialized formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
These capsules may be used to treat a variety of conditions. They are often prescribed for mania, aggression, and agitation associated with dementia. Valproate Sodium 250 mg Slow Release Capsules may also be beneficial for certain types of anxiety disorders, such as panic disorder, social anxiety disorder, and post-traumatic stress disorder.
In addition to these uses, Valproate Sodium 250 mg Slow Release Capsules may be used to manage certain types of chronic pain. This includes neuropathic pain, fibromyalgia, and chronic migraines. However, it is crucial to consult with a healthcare professional before using Valproate Sodium 250 mg Slow Release Capsules to treat any condition. Always seek professional advice if you have any questions about the use of this medication for any condition.
Valproate Sodium 250 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the medication over an extended period of time, offering sustained therapeutic effects.
The slow release formulation reduces the dosing frequency and offers sustained therapeutic effects. This can lead to improved patient compliance, especially for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
The slow release mechanism works by gradually releasing the medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which encapsulates the medication and releases it slowly.
The dosing frequency of Valproate Sodium 250 mg Slow Release Capsules is typically less than that of traditional medications due to its slow release formulation. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
Improved patient compliance can lead to better treatment outcomes. When patients take their medications as prescribed, they are more likely to achieve the desired therapeutic effects and less likely to experience unwanted side effects.
As with any medication, Valproate Sodium 250 mg Slow Release Capsules can cause side effects. However, the slow release formulation is designed to minimize these effects. Any potential side effects should be discussed with your healthcare provider.
Valproate Sodium 250 mg Slow Release Capsules is a prescription medication and should only be taken under the supervision of a healthcare provider. It is important to discuss your medical history and any other medications you are currently taking with your healthcare provider before starting this medication.
No, you should not stop taking Valproate Sodium 250 mg Slow Release Capsules without consulting your healthcare provider. Stopping the medication abruptly can lead to withdrawal symptoms or a return of your symptoms.
If you miss a dose of Valproate Sodium 250 mg Slow Release Capsules, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
